logo

Akebia Therapeutics Inc.: Rising -37.70% from 52-Week Low, Can the Stock Stay Afloat?

HCCC Stock

In terms of market performance, Akebia Therapeutics Inc. had a somewhat regular. The highest value for the stock in the past year was $2.48 on 03/28/24, while the lowest value was $0.78 on 10/26/23.

52-week price history of AKBA Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Akebia Therapeutics Inc.’s current trading price is -37.70% away from its 52-week high, while its distance from the 52-week low is 98.05%. The stock’s price range for this period has remained between $0.78 and $2.48. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.13 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.59 million over the last three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Financial Performance and Market Capitalization

Akebia Therapeutics Inc. (AKBA) has experienced a quarterly rise of 5.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 324.90M and boasts a workforce of 167 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2753, with a change in price of +0.4350. Similarly, Akebia Therapeutics Inc. recorded 2,269,188 in trading volume during the last 100 days, posting a change of +40.28%.

AKBA Stock Stochastic Average

As of today, the raw stochastic average of Akebia Therapeutics Inc. over the past 50 days is 81.43%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 98.21%. Additionally, the Stochastic %K and %D values for the company were 80.65% and 68.55%, respectively, over the past 20 days.

AKBA Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 24.60% this year. Over the last six months, there has been a weaker performance of 12.77%. The price of AKBA fallen by 17.94% during the last 30 days period. For the last 5-days stocks have improved 17.94%.

Most Popular